Skip to main content
Clinical Trials/NCT01737411
NCT01737411
Unknown
Phase 1

Surgical vs. Medical Treatment of Urge Urinary Incontinence in Women

Klinikum der Universität Köln1 site in 1 country120 target enrollmentJanuary 2013

Overview

Phase
Phase 1
Intervention
solifenacin
Conditions
Urge Urinary Incontinence
Sponsor
Klinikum der Universität Köln
Enrollment
120
Locations
1
Primary Endpoint
cure from urge urinary symptoms
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to determine if pelvic surgery can improve urge urinary incontinence in women more than standard medical treatment.

Detailed Description

Urge Urinary Incontinence affects 30% of postmenopausal women. The etiology is unknown therefore treatment is symptomatic. For that purpose the nerval stimulation of the bladder muscle is interfered by several drugs, e.g. solifenacin. We observed that the surgical repair of critical pelvic structures, i.e. the uteri-sacral ligaments (USL) can restore continence in a considerable number of patients. In this study the surgical treatment is compared with the solifenacin treatment. According to outcome after three months patients who are still incontinent are referred to the opposite treatment group. Outcome will be differentiated in cure (primary aim) and improvement of symptoms (secondary aim).

Registry
clinicaltrials.gov
Start Date
January 2013
End Date
June 2018
Last Updated
11 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Female

Investigators

Sponsor
Klinikum der Universität Köln
Responsible Party
Principal Investigator
Principal Investigator

Professor Dr. Wolfram Jäger

Professor

Klinikum der Universität Köln

Eligibility Criteria

Inclusion Criteria

  • urge urinary incontinence

Exclusion Criteria

  • stress urinary incontinence
  • cancer disease of the females genital tract
  • pregnancy
  • neurologic/psychological reasons for incontinence
  • body weight \>100kg
  • previous urogynecological surgery (TVT)
  • syndrome of dry overactive bladder (\>20 micturitions within 24 hours)

Arms & Interventions

solifenacin

10 mg solifenacin per day for three months

Intervention: solifenacin

cesa/vasa

repair of USL

Intervention: cesa/vasa

Outcomes

Primary Outcomes

cure from urge urinary symptoms

Time Frame: 12 months

At the start of the study urge symptoms are categorized from 0 (no symptom for the specific item) to 2 (worst expression of symptom). Cure is defined when sum of category points is 0, improvement is defined when category points are less after than before treatment

Secondary Outcomes

  • cure from urge urinary symptoms(12 months)

Study Sites (1)

Loading locations...

Similar Trials